{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:03:16Z","timestamp":1740106996542,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00423-020-01970-4","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T08:02:51Z","timestamp":1598515371000},"page":"939-947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic impact of abutment to the branches of the superior mesenteric artery in borderline resectable pancreatic cancer"],"prefix":"10.1007","volume":"405","author":[{"given":"Taisuke","family":"Imamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8740-8468","authenticated-orcid":false,"given":"Yusuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiichi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiyasu","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhisa","family":"Ohgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Todaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Fukutomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiko","family":"Uesaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"1970_CR1","unstructured":"Network NCC Clinical practice guidelines in oncology. Pancreatic Adenocarcinoma Version 2.2018. https:\/\/www2.tri-kobe.org\/nccn\/guideline\/pancreas\/english\/pancreatic.pdf. Accessed 20 October 2018"},{"issue":"12","key":"1970_CR2","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1245\/s10434-013-3129-9","volume":"20","author":"F Motoi","year":"2013","unstructured":"Motoi F, Ishida K, Fujishima F, Ottomo S, Oikawa M, Okada T, Shimamura H, Takemura S, Ono F, Akada M, Nakagawa K, Katayose Y, Egawa S, Unno M (2013) Neoadjuvant chemotherapy with gemcitabine and S-1 for resectable and borderline pancreatic ductal adenocarcinoma: results from a prospective multi-institutional phase 2 trial. Ann Surg Oncol 20(12):3794\u20133801. https:\/\/doi.org\/10.1245\/s10434-013-3129-9","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1970_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/sla.0000000000001547","volume":"264","author":"H Takahashi","year":"2016","unstructured":"Takahashi H, Akita H, Tomokuni A, Kobayashi S, Ohigashi H, Fijiwara Y, Yano M, Sakon M, Ishikawa O (2016) Preoperative gemcitabine-based chemoradiation therapy for borderline resectable pancreatic cancer: impact of venous and arterial involvement status on surgical outcome and pattern of recurrence. Ann Surg 264(6):1091\u20131097. https:\/\/doi.org\/10.1097\/sla.0000000000001547","journal-title":"Ann Surg"},{"issue":"6","key":"1970_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00534-013-0595-1","volume":"20","author":"H Kato","year":"2013","unstructured":"Kato H, Usui M, Isaji S, Nagakawa T, Wada K, Unno M, Nakao A, Miyakawa S, Ohta T (2013) Clinical features and treatment outcome of borderline resectable pancreatic head\/body cancer: a multi-institutional survey by the Japanese Society of Pancreatic Surgery. J Hepatobiliary Pancreat Sci 20(6):601\u2013610. https:\/\/doi.org\/10.1007\/s00534-013-0595-1","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"6","key":"1970_CR5","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/MPA.0b013e31827b2d7c","volume":"42","author":"S Yamada","year":"2013","unstructured":"Yamada S, Fujii T, Sugimoto H, Nomoto S, Takeda S, Kodera Y, Nakao A (2013) Aggressive surgery for borderline resectable pancreatic cancer: evaluation of National Comprehensive Cancer Network guidelines. Pancreas 42(6):1004\u20131010. https:\/\/doi.org\/10.1097\/MPA.0b013e31827b2d7c","journal-title":"Pancreas"},{"issue":"8","key":"1970_CR6","doi-asserted-by":"publisher","first-page":"e161137","DOI":"10.1001\/jamasurg.2016.1137","volume":"151","author":"MH Katz","year":"2016","unstructured":"Katz MH, Shi Q, Ahmad SA, Herman JM, Marsh Rde W, Collisson E, Schwartz L, Frankel W, Martin R, Conway W, Truty M, Kindler H, Lowy AM, Bekaii-Saab T, Philip P, Talamonti M, Cardin D, LoConte N, Shen P, Hoffman JP, Venook AP (2016) Preoperative modified FOLFIRINOX treatment followed by capecitabine-based chemoradiation for borderline resectable pancreatic cancer: alliance for clinical trials in oncology trial A021101. JAMA Surg 151(8):e161137. https:\/\/doi.org\/10.1001\/jamasurg.2016.1137","journal-title":"JAMA Surg"},{"issue":"8","key":"1970_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.6004\/jnccn.2014.0106","volume":"12","author":"MA Tempero","year":"2014","unstructured":"Tempero MA, Malafa MP, Behrman SW, Benson AB 3rd, Casper ES, Chiorean EG, Chung V, Cohen SJ, Czito B, Engebretson A, Feng M, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Lowy AM, Ma WW, Merchant NB, Mulvihill SJ, Muscarella P 2nd, Nakakura EK, Obando J, Pitman MB, Reddy S, Sasson AR, Thayer SP, Weekes CD, Wolff RA, Wolpin BM, Burns JL, Freedman-Cass DA (2014) Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw 12(8):1083\u20131093","journal-title":"J Natl Compr Cancer Netw"},{"issue":"6","key":"1970_CR8","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/SLA.0000000000001065","volume":"262","author":"Y Inoue","year":"2015","unstructured":"Inoue Y, Saiura A, Yoshioka R, Ono Y, Takahashi M, Arita J, Takahashi Y, Koga R (2015) Pancreatoduodenectomy with systematic mesopancreas dissection using a supracolic anterior artery-first approach. Ann Surg 262(6):1092\u20131101. https:\/\/doi.org\/10.1097\/SLA.0000000000001065","journal-title":"Ann Surg"},{"issue":"12","key":"1970_CR9","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M (2014) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg 12(12):1500\u20131524. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.014","journal-title":"Int J Surg"},{"issue":"9","key":"1970_CR10","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.ejso.2016.01.006","volume":"42","author":"B Ielpo","year":"2016","unstructured":"Ielpo B, Duran H, Diaz E, Fabra I, Caruso R, Ferri V, Malave L, Hidalgo M, Alvarez R, Plaza C, Quijano Y, Vicente E (2016) Preoperative treatment with gemcitabine plus nab-paclitaxel is a safe and effective chemotherapy for pancreatic adenocarcinoma. Eur J Surg Oncol 42(9):1394\u20131400. https:\/\/doi.org\/10.1016\/j.ejso.2016.01.006","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"1970_CR11","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1007\/s00268-012-1742-6","volume":"36","author":"T Sugiura","year":"2012","unstructured":"Sugiura T, Uesaka K, Ohmagari N, Kanemoto H, Mizuno T (2012) Risk factor of surgical site infection after pancreaticoduodenectomy. World J Surg 36(12):2888\u20132894","journal-title":"World J Surg"},{"issue":"4","key":"1970_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000445014","volume":"33","author":"A Nakao","year":"2016","unstructured":"Nakao A (2016) The mesenteric approach in pancreatoduodenectomy. Dig Surg 33(4):308\u2013313. https:\/\/doi.org\/10.1159\/000445014","journal-title":"Dig Surg"},{"issue":"10041","key":"1970_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","volume":"388","author":"K Uesaka","year":"2016","unstructured":"Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T, Ohashi Y (2016) Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet 388(10041):248\u2013257","journal-title":"Lancet"},{"issue":"2","key":"1970_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205\u2013213","journal-title":"Ann Surg"},{"issue":"3","key":"1970_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.surg.2016.11.014","volume":"161","author":"C Bassi","year":"2017","unstructured":"Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, Conlon K, Del Chiaro M, Falconi M, Fernandez-Cruz L, Fernandez-Del Castillo C, Fingerhut A, Friess H, Gouma DJ, Hackert T, Izbicki J, Lillemoe KD, Neoptolemos JP, Olah A, Schulick R, Shrikhande SV, Takada T, Takaori K, Traverso W, Vollmer CR, Wolfgang CL, Yeo CJ, Salvia R, Buchler M (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 161(3):584\u2013591","journal-title":"Surgery"},{"issue":"1","key":"1970_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O","volume":"19","author":"M Mazumdar","year":"2000","unstructured":"Mazumdar M, Glassman JR (2000) Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. Stat Med 19(1):113\u2013132","journal-title":"Stat Med"},{"issue":"4","key":"1970_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/SLA.0b013e318263da2f","volume":"257","author":"IT Konstantinidis","year":"2013","unstructured":"Konstantinidis IT, Warshaw AL, Allen JN, Blaszkowsky LS, Castillo CF, Deshpande V, Hong TS, Kwak EL, Lauwers GY, Ryan DP, Wargo JA, Lillemoe KD, Ferrone CR (2013) Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a \u201ctrue\u201d R0 resection? Ann Surg 257(4):731\u2013736. https:\/\/doi.org\/10.1097\/SLA.0b013e318263da2f","journal-title":"Ann Surg"},{"issue":"13","key":"1970_CR18","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1200\/jco.2012.43.3680","volume":"31","author":"H Ueno","year":"2013","unstructured":"Ueno H, Ioka T, Ikeda M, Ohkawa S, Yanagimoto H, Boku N, Fukutomi A, Sugimori K, Baba H, Yamao K, Shimamura T, Sho M, Kitano M, Cheng AL, Mizumoto K, Chen JS, Furuse J, Funakoshi A, Hatori T, Yamaguchi T, Egawa S, Sato A, Ohashi Y, Okusaka T, Tanaka M (2013) Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. J Clin Oncol Off J Am Soc Clin Oncol 31(13):1640\u20131648. https:\/\/doi.org\/10.1200\/jco.2012.43.3680","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"1970_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/mpa.0000000000000314","volume":"44","author":"F Petrelli","year":"2015","unstructured":"Petrelli F, Coinu A, Borgonovo K, Cabiddu M, Ghilardi M, Lonati V, Aitini E, Barni S (2015) FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies. Pancreas 44(4):515\u2013521. https:\/\/doi.org\/10.1097\/mpa.0000000000000314","journal-title":"Pancreas"},{"issue":"1","key":"1970_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/SLA.0000000000000867","volume":"261","author":"CR Ferrone","year":"2015","unstructured":"Ferrone CR, Marchegiani G, Hong TS, Ryan DP, Deshpande V, McDonnell EI, Sabbatino F, Santos DD, Allen JN, Blaszkowsky LS, Clark JW, Faris JE, Goyal L, Kwak EL, Murphy JE, Ting DT, Wo JY, Zhu AX, Warshaw AL, Lillemoe KD, Fernandez-del Castillo C (2015) Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg 261(1):12\u201317. https:\/\/doi.org\/10.1097\/SLA.0000000000000867","journal-title":"Ann Surg"},{"issue":"4","key":"1970_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1477-2574.2009.00055.x","volume":"11","author":"CS Verbeke","year":"2009","unstructured":"Verbeke CS, Menon KV (2009) Redefining resection margin status in pancreatic cancer. HPB (Oxford) 11(4):282\u2013289. https:\/\/doi.org\/10.1111\/j.1477-2574.2009.00055.x","journal-title":"HPB (Oxford)"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-020-01970-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-020-01970-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-020-01970-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:04:28Z","timestamp":1630022668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-020-01970-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1970"],"URL":"https:\/\/doi.org\/10.1007\/s00423-020-01970-4","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"type":"print","value":"1435-2443"},{"type":"electronic","value":"1435-2451"}],"subject":[],"published":{"date-parts":[[2020,8,27]]},"assertion":[{"value":"23 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}